You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Outcomes of establishing a neonatal peripheral vascular access team
  1. Matheus van Rens1,
  2. Kevin Hugill2,
  3. Mohammed Abdul Khader Gaffari1,
  4. Airene V Francia1,
  5. Thiruveni Ramkumar1,
  6. Krisha L P Garcia1,
  7. Fredericus H J van Loon3
  1. 1 Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar
  2. 2 Nursing and Midwifery Education, Hamad Medical Corporation, Doha, Qatar
  3. 3 Anaesthesiology and Intensive Care, Catharina Hospital, Eindhoven, North Brabant, The Netherlands
  1. Correspondence to Matheus van Rens, Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar; matheusvanrens{at}gmail.com

https://doi.org/10.1136/archdischild-2021-322764

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Intravenous vascular access (VA) is essential in neonatal intensive care units (NICUs). Short peripheral intravenous catheters (PIVCs) are the most frequently used short-term device.1 Many unmodifiable and potentially modifiable factors affect the incidence of complications, contributing to the success or failure of therapy.2 Numerous interventions such as evidence-based care bundles, innovations in device design and manufacturer are targeted at reducing the incidence and severity of complications.3 Internationally, specialist multiprofessional teams for central venous access are widely established4 but evidence about the impacts of teams for managing peripheral intravenous access is less evident.

    Therefore, we aimed to examine the impacts of a dedicated neonatal peripheral vascular access team (NeoVAT) on key clinical and organisational quality measures of infusion therapy. We retrospectively …

    View Full Text

    Footnotes

    • Contributors MvR was the main investigator, conceptualised and designed the study, coordinated, and supervised data collection, drafted the initial manuscript, and reviewed and revised the manuscript. KH drafted the initial manuscript and reviewed and revised the manuscript. MAKG and TR critically reviewed the manuscript for important intellectual content. ALF and KLPG designed the data collection instruments, collected data, and reviewed and revised the manuscript. FHJvL carried out the initial analyses, and critically reviewed the manuscript for important intellectual content and revised the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.